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Abstract: Leiomyomatosis peritonealis disseminate (LPD) is a rare benign disease of unknown etiology of women in reproductive 
age. A few reported cases of association with endometriosis have been described suggesting a possible origin from submesothelial 
multipotential cells. We present two cases of LPD associated with endometriosis expressing smooth muscle metaplasia, and some of 
the nodules with aspects of uterus-like mass. Laparoscopy, gross findings, and the pathological and immunohistochemical study of the 
surgical specimens were described. Our findings suggest an endometriotic origin for the LPD and indicate that the therapeutic approach 
might contemplate the surgical reduction of the nodules and endometriosis treatment.
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Introduction
Leiomyomatosis peritonealis disseminata (LPD) is a 
rare benign disease of unknown etiology in women 
of reproductive age.1 It is characterized by multiple 
subperitoneal or peritoneal smooth muscle tumors of 
varying sizes on the omentum and peritoneal surfaces. 
A possible origin from submesothelial multipotential 
cells has been suggested, although it is not clear if the 
stimulus  to  smooth  cell  differentiation  is  hormonal, 
genetic,  or  both.1,2  The few reported cases of association 
between LPD and endometriosis favor a hypothesis of 
a common origin for both the lesions.2–6 However, the 
mechanisms involved in this association are unknown. 
It  is  not  clear  whether  the  leiomyomatous  nodules 
originate from the endometriosis foci, or if both the 
conditions correspond to different clinicopathological 
presentations of a common metaplastic phenomenon. 
Another  extremely  rare  condition,  also  possibly 
originating  from  the  submesothelial  multipotential 
cells, is the uterus-like mass, defined as an extrauterine 
mass composed of smooth muscle and a central cavity 
lined by endometrium, resembling a normal uterus.7–10 
The peritoneal localization of benign smooth muscle 
cells lesions, such as leiomyomas or uterus-like mass, 
is an intriguing fact that offers an unique opportunity to 
understand the mechanisms of extrauterine mullerian 
differentiation,  known  as  mullerianosis.9  In  this 
study, we describe two cases of LPD associated with 
endometriosis, with some of the nodules resembling 
uterus-like mass, and with clear evidence of smooth-
muscle  metaplasia  in  the  stromal  component  of 
endometriosis. Furthermore, we discuss the origin of 
peritoneal  smooth  muscle  lesions  from  endometrial 
stroma.
Methods and case Reports
We describe two cases referred to one of the authors 
(FMC) to review the hematoxylin-eosin slides and 
perform the immunohistochemical study.
Case 1—A 32-year-old previously healthy nullipa-
rous woman, who had a history of abnormal vaginal 
bleeding in 2004. In that occasion, she was submitted 
to  a  hysteroscopic  myomectomy.  She  remained 
asymptomatic until 2008, when she presented a   pelvic 
mass of 86.0 mm at ultrasound examination, associated 
with serum CA-125 of 138 U/mL. At   laparoscopy, 
there were innumerable nodules involving pelvic and 
abdominal peritoneal surfaces, omentum, and the left 
ovary, varying from few millimeters up to 50.0 mm. 
Some of the nodules were associated with the central 
cystic cavities filled with dark brown viscous fluid. 
There  were  also  classical  peritoneal  endometriotic 
lesions of red flame-like type. Some of the nodules 
had  been  excised  for  pathological  study. After  the 
diagnosis, she received goserelin for 6 months. The 
control magnetic resonance imaging (MRI) showed 
significant reduction in the nodules and the CA-125 
was normal. Fifteen months later, the serum CA-125 
was 36.0 U/mL and the MRI revealed a left ovarian 
mass  of  65.0  mm  associated  with  multiple    pelvic 
nodules  measuring  up  to  45.0  mm  in  diameter. 
  Computed tomography (CT) scan of the lungs showed 
28 nodules (Fig. 1). She received goserelin for another 
6 months, but CT scan did not show any change in 
the lesions. Now, she has been taking anastrozole for 
6 months, with stable disease. The last serum CA-125 
was 69.1 U/mL.
Case 2—A 41-year-old woman was submitted to 
laparoscopy for surgical treatment of deep infiltrating 
endometriosis  involving  rectovaginal  space,  ovary, 
peritoneum  and  rectosigmoid.  She  complained 
of  pelvic  pain,  dysmenorrhea,  intestinal  transit 
disturbances  and  proctalgy.  There  was  no  sign  or 
symptom  of  anemia,  weight  loss,  or  weakness. At 
laparoscopy, there were innumerable nodules ranging 
from few millimeters to 20.0 mm, involving all the 
peritoneal surfaces, although more numerous in the 
pelvis, and not infiltrative in the subjacent viscera. 
Greater  and  lesser  omentums  were  extensively 
involved. The nodules were solid, firm, and white, 
Figure 1. CT scan of lungs showing numerous nodules.Leiomyomatosis peritonealis and endometriosis
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but  some  of  those  localized  in  the  left  paracolic 
gutter  were  darker,  suggesting  being  filled  with 
hemorrhagic material (Fig. 2). There were peritoneal 
superficial endometriotic lesions and an endometriotic 
ovarian cyst at the left side measuring 25.0 mm. As 
the  lesions  were  unresectable,  we  carried  out  left 
salpingooophorectomy  and  partial  excision  of  the 
lesions  in  the  left  paracolic  gutter,  vesicouterine 
peritoneum,  and  pouch  of  Douglas.  The  specimen 
was sent for pathological examination. Patient has 
been  receiving  medroxyprogesterone  for  4  months 
without signs of disease progression.
pathological study
Microscopic examination of the lesions of the two 
cases was very similar and characterized by multiple 
nodular proliferation comprising bundles of spindle-
shaped smooth muscle cells, without atypia, necrosis, 
or mitosis. The nodules were embedded in fat tissue, 
and  were  mostly  well  circumscribed,  but  some  of 
them had an infiltrative border (Fig. 3A and B). Some 
nodules  presented  central  area  with  stromal  and 
epithelial endometrial tissue admixed with the smooth 
muscle cells, creating an aspect of the uterine corpus 
wall (Fig. 3C and D). Some glands were cystically 
dilated. Variable amounts of blood, necrotic-appearing 
endometrium,  fibrosis,  and  hemosiderin-laden 
macrophages were associated with the endometrial 
tissue.
We selected to immunohistochemistry study either 
areas of pure leiomyoma as sections of the lesions 
containing  both  the  components  (smooth  mus-
cle  and  endometrial).  The  histological  sections 
were  immunostained  for  estrogen  receptor  (ER), 
progesterone receptor (PR), CD10 (Common Acute 
Lymphocytic Leukemia Antigen or CALLA), smooth 
muscle actin (SMA), desmin, CD117 (c-kit), calretinin, 
Wilms’  tumor  suppressor  gene  (WT1),  Protein 
gene  product  (PGP  9.5),  and  Ki-67.  The  sources 
and dilutions of the antibodies and epitope retrieval 
methods used are listed in Table 1. Bound antibodies 
for ER, PR, Ki-67, WT1, CD17, CD10, and PGP 9.5 
were detected using Novolink method (Leica, USA). 
For calretinin, we used Envision (Dako, USA) and 
for SMA and desmin we used avidin-biotin complex 
(ABC) method (Vector, USA). Negative and positive 
controls were used for each antibody. For positive 
controls we use archival human tissues proved posi-
tive for the desired antigen. For negative controls, the 
primary antibody was omitted.
On  immunohistochemistry  examination,  spindle 
cells of smooth muscle areas were strongly positive 
for desmin (Fig. 4A), smooth muscle actin (SMA), 
WT-1, ER and PR. Few smooth muscle cells were 
also   positive for CD10 and CD117. The endometrial 
stromal  cells  were  diffusely  positive  for  CD10 
(Fig. 4B), ER, PR, smooth muscle actin (Fig. 4C), 
and  WT-1.  The  stromal  endometrial  component 
showed scattered morphological endometrial spindle 
cells with immunoexpression of desmin (Fig. 4D). 
Both  the  mesenchymal  components  were  negative 
for   calretinin and PGP 9.5. The glands were diffusely 
positive for ER and PR.
Figure 2. Laparoscopic image of Case 2 showing multiple nodules of 
various sizes on the peritoneal surfaces, characteristic of leiomyomatosis 
peritoneal disseminata, one of them (*) associated with endometriosis.
Figure 3. Microscopic presentation of the nodules. (A) Well-circumscribed 
leiomyomatous nodule attached to peritoneal surface, focally   infiltrative in 
the  subjacent  adipose  tissue  (original  magnification  100×).  (B)  Magnification 
of the nodule in A (original magnification 400×). (c) Nodule composed of 
smooth muscle tissue in the periphery   associated with the central area 
of stromal and glandular endometrial tissue, mimicking   corpus   uterine 
wall  (original  magnification  100×).  (D)  Magnification  of  nodule  in  C 
  showing the transition between stromal endometrial and smooth muscle 
  component (original magnification 400×).Carvalho et al
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Discussion
Multiple peritoneal leiomyomas were first described 
in a case report in 1952, as a feature associated with 
a granulosa cell ovarian tumor.11 However, only in 
1965,  the  condition  was  named  “leiomyomatosis 
peritonealis  disseminata”  and  characterized  as  an 
entity  related  to  uterine  leiomyomas.12  Since  then, 
isolated cases have been described, without consensus 
about the histogenesis of this rare condition. First, it 
was suggested that LPD corresponded to a benign 
reparative  process  in  which  fibroblasts  replaced 
subperitoneal  deciduas.13  The  first  case  of  LPD 
associated  with  endometriosis  was  described  in 
1980,  when  the  authors  suggested  a  metaplasia  of 
the  subcoelomic  mesenchyme  in  the  pathogenesis 
of the peritoneal smooth cell lesions.14 The largest 
series of LPD was published in 1982.15 The authors 
described 20 patients with an age ranged from 22 to 
41 years; half of them were pregnant or immediately 
postpartum. Most of the nodules were composed of 
smooth muscle cells, but myofibroblasts, fibroblasts, 
collagen and decidual stromal cells were also noted. 
One  of  the  patients  had  extensive  endometriosis, 
including  stromal  endometrial  cells  associated 
with smooth muscle nodules. However, the authors 
interpreted this association as very rare and probably 
unrelated. On the other hand, they discussed the role 
of  primitive  mesenchymal  stem  cell  as  the  origin 
of  fibroblasts,  myofibroblasts,  stromal  endometrial 
cells, decidual cells, and even endometrial glandular 
epithelium. In that study, the authors emphasized the 
hormonal role in the initiation and/or promotion of 
the LPD.15 Various reports of association between LPD 
and endometriosis have been described, reinforcing 
the  theory  of  metaplastic  origin  of  LPD.2–6,14 
However, it is difficult to admit that a rare disease, 
such as LPD, can have the same origin and hormonal 
influence  as  that  of  endometriosis,  an  extremely 
common  condition.  On  the  other  hand,  smooth 
muscle metaplasia is an event recognizable in stromal 
endometriosis,16 which could be demonstrated in our 
cases. We can postulate that LPD is a rare event in 
the spectrum of endometriosis, and we can speculate 
that even those cases where endometrial tissue is not 
found can correspond to a special clinicopathological 
form of this disease. However, we cannot ignore the 
important insights of Batt et al17 when defining the 
mullerianosis  condition—misplaced  endometrial  or 
mullerian tissue—and the possible explanation for the 
Table 1. Reagents and methods used for immunohistochemical analysis.
Antigen clone/source Dilution epitope retrieval method
eR (estrogen receptor) Sp1/Neomarkers 1:1000 pressure cooker
pR (progesterone receptor) pgR636/Dako 1:1600 pressure cooker
CD10 270/Novocastra 1:200 Steamer 60
Smooth muscle actin 1A4/Dako 1:600 Steamer 60
Desmin D33/Dako 1:3200 Microwave oven
c-kit (CD117) polyclonal/Dako 1:450 Microwave oven
Calretinin Sp13/Neomarkers 1:400 Steamer 60
WT-1 6FH2/Dako 1:400 pressure cooker
protein gene product (pGp 9.5) polyclonal/Dako 1:3200 Steamer 60
Ki-67 MIB1/Dako 1:4800 pressure cooker
pressure cooker: Citrate buffer (pH 6) (Tender Cooker, Nordic Wave, USA); Microwave: Citrate buffer (pH 6), 15 min (eletrolux, 900W).
CD10
B A
D C
Desmin SMA
Desmin
Figure 4. Immunohistochemical study. (A) Smooth muscle cells strongly 
positive to desmin (original magnification 100×). (B) endometrial stroma 
inside the leiomyomatous nodule positive to CD10 (original magnification 
100×).  (c)  endometrial  stroma  cells  positive  to  Smooth  Muscle 
Actin  (SMA)  (original  magnification  100×).  (D)  Scattered  endometrial 
stromal  cells  of  the  endometriotic  tissue  positive  to  desmin  (original 
magnification 400×).Leiomyomatosis peritonealis and endometriosis
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extrauterine uterus-like mass, according this concept, 
as  a  development  entity.9  Our  endometriosis  foci 
within the smooth muscle nodules showed evidence of 
muscle metaplasia, and besides, the transition between 
both the components were not well demarcated and 
the borders of the muscle nodules were infiltrative 
at  times,  a  finding  more  likely  to  be  observed  in 
endometriosis than in a development entity, such as 
mullerianosis. Clement, in his excellent review about 
endometriosis, recognizes smooth muscle metaplasia, 
that can be focal or extensive, constituting entities 
like  endomyometriosis  and  uterus-like  mass.18 The 
extensive replacement of the stromal component of 
endometriosis  was  initially  described  by  Cozzutto 
in 1981.19 In the same year, Rohlfing described the 
same  association  with  the  description  of  nodules 
resembling  uterus  miniature.20  The  uterus-like 
mass  is  characterized  by  a  central  cavity  lined  by 
endometrium surrounded by a thick wall composed 
of smooth muscle and is still a very rare condition 
with a questionable histogenesis.8–10,16,21,22 Our cases 
show the classical presentation of LPD, but some of 
the nodules share many similarities with miniature 
uterus. The association with endometriosis are more 
striking  than  some  of  the  previously  reports2,3,5,15 
and the aspects of classical endometriosis and LPD 
merge subtlety with the uterus-like appearance. The 
clinical  evolutions  of  the  two  cases  as  the  gross 
presentation of the disease are highly consistent with 
endometriosis.  Besides,  the  pathological  findings 
clearly demonstrate the endometriosis associated with 
smooth  muscle  metaplasia  and  transition  between 
stromal endometriotic cells and muscle nodules. It 
is possible that most of the LPD cases, even those 
without  a  clear  association  with  endometriosis, 
correspond to a variant of the endometriosis disease. 
Other explanations have been suggested, such as a 
possible iatrogenic cause for the disease.1 This latter 
hypothesis invites us to think about a possible parallel 
between the implant theory of endometriosis and the 
smooth  muscle  implants  occurring  in  leiomyoma 
morcellation, as suggested by Al-Talib and Tulandi.1 
A  possible  implantation  theory  is  consistent  with 
the  role  of  mullerian  stem  cells  located  in  topic 
endometrium as the generator of most of the cases of 
endometriosis and, probably, also the LPD as well. This 
possible relation to endometriosis might be considered 
at the moment of therapeutic planning. Although there 
is no consensus about the ideal management of LPD,1 
surgery and estrogenic suppression are the mainstay. 
Hormonal  treatment  includes  GnRH,  aromatase 
inhibitors,  and  megestrol  acetate,  and  has  been 
described  as  useful  in  many  cases.23–26  Similar  to 
endometriosis, some cases of LPD can be resistant to 
hormonal suppression, and some lesions can present 
local and distant recurrences.27 For such aggressive 
cases, chemotherapy with doxorubicin and carbazine 
can be administered.27
conclusions
Our findings suggest an endometriotic origin for the 
LPD and indicate that the therapeutic approach might 
contemplate  surgical  reduction  of  the  nodules  and 
endometriosis control. Treatment could be started by 
decreasing the estrogen level either by the adminis-
tration of GnRHa or an aromatase inhibitor. In severe 
cases, particularly those not responsive to hormonal 
blockage, oophorectomy must be considered.
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